[Summary of Kimberly-Clark Q4 2024 Earnings Call]

Date: January 2025
Period Ending: December 31, 2024

## Financial Highlights:
*   **Net Sales:** $4.9 billion (-0.8% YoY). Decline due to FX (-1.7%) and PPE divestiture (-1.4%).
*   **Organic Sales:** +2.3% (Volume +1.5%, Price +0.6%, Mix +0.1%).
*   **EPS:** $1.34 (Reported), $1.50 (Adjusted).
*   **Gross Margin:** Expansion driven by strong productivity savings.
*   **Full Year 2024:** Net Sales $20.1 billion (-1.8%). Adjusted EPS $7.30 (+11.1%).

## Strategic Highlights:
*   **Volume Growth:** Q4 saw the highest volume growth of the year (+1.5%), validating the "Powering Care" strategy.
*   **Market Share:** Weighted average share +10bps. Strong gains in North America Diapers, Adult Care, and Tissue.
*   **Productivity:** Generated $745 million in gross supply chain productivity (5.9% of COGS).
*   **Outlook 2025:** Expecting Mid-to-High Single Digit Adjusted EPS growth (constant currency).

Note: This quarter marked a shift to volume-led growth, a key pillar of the new strategy.
